Fisher & Paykel Healthcare Co Ltd 2022 AR2
The report highlights Fisher & Paykel Healthcare's financial and sustainability performance for the fiscal year ended 31 March 2022. Despite a decline in global hospitalisations requiring respiratory support, the company delivered strong results, driven by its Hospital and Homecare product groups. Key achievements include the launch of the Airvo 3 device, progress on manufacturing facilities in Mexico and New Zealand, and the official registration of the Fisher & Paykel Healthcare Foundation. Additionally, the company made progress toward its science-based climate targets and expanded its global sales footprint to 53 countries.
Company: Fisher & Paykel Healthcare Co Ltd
Sector: Manufacturing
Country: New Zealand
Year: 2022
Type: AR2
Pages: 146
Fisher & Paykel Healthcare Co Ltd
The report highlights Fisher & Paykel Healthcare's financial and sustainability performance for the fiscal year ended 31 March 2022. Despite a decline in global hospitalisations requiring respiratory support, the company delivered strong results, driven by its Hospital and Homecare product groups. Key achievements include the launch of the Airvo 3 device, progress on manufacturing facilities in Mexico and New Zealand, and the official registration of the Fisher & Paykel Healthcare Foundation. Additionally, the company made progress toward its science-based climate targets and expanded its global sales footprint to 53 countries.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Apr 1, 2021 - Mar 31, 2022
Fiscal Year
2022
Published
May 24, 2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Water Consumption
Women on Board
Women in Management
Workplace Fatalities
Employees